BSGM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biosig Technologies Inc (BSGM).


$25.68M Market Cap.

As of 04/16/2025 5:00 PM ET (MRY) • Disclaimer

BSGM Market Cap. (MRY)


BSGM Shares Outstanding (MRY)


BSGM Assets (MRY)


Total Assets

$842.00K

Total Liabilities

$2.26M

Total Investments

$17.00K

BSGM Income (MRY)


Revenue

$40.00K

Net Income

-$10.33M

Operating Expense

$12.90M

BSGM Cash Flow (MRY)


CF Operations

-$4.76M

CF Investing

$0

CF Financing

$4.71M

BSGM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

-

0%

-

BSGM Balance Sheet (MRY)


Metric

2024

2023

Total Assets

$842,000 (-53.17%)

$1,798,000

Assets Current

$344,000 (-34.85%)

$528,000

Assets Non-Current

$498,000 (-60.79%)

$1,270,000

Goodwill & Intangible Assets

$269,000 (-6.60%)

$288,000

Shareholders Equity

-$1,544,000 (48.84%)

-$3,018,000

Property Plant & Equipment Net

$181,000 (-80.35%)

$921,000

Cash & Equivalents

$142,000 (-25.26%)

$190,000

Accumulated Other Comprehensive Income

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0

Total Investments

$17,000 (-85.83%)

$120,000

Investments Current

$13,000 (-87.38%)

$103,000

Investments Non-Current

$4,000 (-76.47%)

$17,000

Inventory

$0 (0%)

$0

Trade & Non-Trade Receivables

$109,000 (354.17%)

$24,000

Trade & Non-Trade Payables

$2,052,000 (-50.15%)

$4,116,000

Accumulated Retained Earnings (Deficit)

-$255,345,000 (-4.22%)

-$245,015,000

Tax Assets

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0

Total Debt

$102,000 (-77.43%)

$452,000

Debt Current

$102,000 (-70.77%)

$349,000

Debt Non-Current

$0 (0%)

$103,000

Total Liabilities

$2,264,000 (-51.68%)

$4,685,000

Liabilities Current

$2,264,000 (-50.59%)

$4,582,000

Liabilities Non-Current

$0 (0%)

$103,000

BSGM Income Statement (MRY)


Metric

2024

2023

Revenues

$40,000 (122.22%)

$18,000

Cost of Revenue

$0 (0%)

$0

Selling General & Administrative Expense

$11,629,000 (-49.61%)

$23,077,000

Research & Development Expense

$832,000 (-83.66%)

$5,092,000

Operating Expenses

$12,902,000 (-54.78%)

$28,530,000

Interest Expense

$11,000 (0%)

$0

Income Tax Expense

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0

Consolidated Income

-$10,339,000 (63.96%)

-$28,690,000

Net Income to Non-Controlling Interests

-$9,000 (-102.56%)

$351,000

Net Income

-$10,330,000 (64.43%)

-$29,041,000

Preferred Dividends Income Statement Impact

$183,000 (1933.33%)

$9,000

Net Income Common Stock

-$10,513,000 (63.81%)

-$29,050,000

Weighted Average Shares

$14,041,748 (91.00%)

$7,351,794

Weighted Average Shares Diluted

$14,041,748 (91.00%)

$7,351,794

Earning Before Interest & Taxes (EBIT)

-$10,319,000 (64.47%)

-$29,041,000

Gross Profit

$40,000 (122.22%)

$18,000

Operating Income

-$12,862,000 (54.89%)

-$28,512,000

BSGM Cash Flow Statement (MRY)


Metric

2024

2023

Net Cash Flow from Investing

$0 (0%)

-$186,000

Net Cash Flow from Financing

$4,710,000 (-72.82%)

$17,332,000

Net Cash Flow from Operations

-$4,758,000 (72.52%)

-$17,313,000

Net Cash Flow / Change in Cash & Cash Equivalents

-$48,000 (71.26%)

-$167,000

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0

Capital Expenditure

$0 (0%)

-$186,000

Issuance (Repayment) of Debt Securities

$500,000 (0%)

$0

Issuance (Purchase) of Equity Shares

$4,210,000 (-72.59%)

$15,361,000

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0

Share Based Compensation

$6,957,000 (-12.80%)

$7,978,000

Depreciation Amortization & Accretion

$504,000 (-22.94%)

$654,000

BSGM Financial Metrics (MRY)


Metric

2024

2023

Gross Margin

100.00% (0.00%)

100.00%

Profit Margin

-26282.50% (83.71%)

-161388.90%

EBITDA Margin

-24537.50% (84.44%)

-157705.60%

Return on Average Equity (ROAE)

670.00% (-88.70%)

5928.60%

Return on Average Assets (ROAA)

-604.50% (26.14%)

-818.40%

Return on Sales (ROS)

-25797.50% (84.01%)

-161338.90%

Return on Invested Capital (ROIC)

503.20% (-88.82%)

4502.50%

Dividend Yield

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.99 (-65.17%)

-1.2

Price to Sales Ratio (P/S)

523.05 (-73.04%)

1,940.06

Price to Book Ratio (P/B)

-16.63 (-19.94%)

-13.87

Debt to Equity Ratio (D/E)

-1.47 (5.54%)

-1.55

Earnings Per Share (EPS)

-0.75 (81.01%)

-3.95

Sales Per Share (SPS)

0 (50.00%)

0

Free Cash Flow Per Share (FCFPS)

-0.34 (85.76%)

-2.38

Book Value Per Share (BVPS)

-0.11 (73.24%)

-0.41

Tangible Assets Book Value Per Share (TABVPS)

0.04 (-80.00%)

0.2

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1

Enterprise Value Over EBITDA (EV/EBITDA)

-2.57 (-73.70%)

-1.48

Asset Turnover

0.02 (360.00%)

0.01

Current Ratio

0.15 (32.17%)

0.12

Dividends

$0 (0%)

$0

Free Cash Flow (FCF)

-$4,758,000 (72.81%)

-$17,499,000

Enterprise Value (EV)

$25,210,044 (-39.97%)

$41,994,093

Earnings Before Tax (EBT)

-$10,330,000 (64.43%)

-$29,041,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$9,815,000 (65.42%)

-$28,387,000

Invested Capital

-$1,731,000 (38.40%)

-$2,810,000

Working Capital

-$1,920,000 (52.64%)

-$4,054,000

Tangible Asset Value

$573,000 (-62.05%)

$1,510,000

Market Capitalization

$25,680,044 (-38.64%)

$41,851,093

Average Equity

-$1,569,000 (-220.20%)

-$490,000

Average Assets

$1,739,000 (-51.01%)

$3,549,750

Invested Capital Average

-$2,050,750 (-217.95%)

-$645,000

Shares

17,234,929 (95.61%)

8,810,756